NuCana is trading at $1.00, down 5.11%, with no fresh company-specific announcement found to explain the decline.
- Recent European patent news was announced September 30, not October 15.
- Biotech was higher while major U.S. indexes were mixed, offering no clear explanation for the drop.
- No verified intraday volume or specific catalyst is available.